ASSCR Rising Star Award

Recognising early career stem cell superstars

It is with great pleasure that we announce the recipients of the 2026 ASSCR Rising Star Awards: Dr Chiara Pavan from The Florey Institute of Neuroscience & Dr Sebastian Bass-Stringer from St Vincent’s Institute of Medical Research.

These prestigious awards recognise their outstanding contributions to stem cell research, leadership, and contributions to our stem cell community.

Dr Chiara Pavan and Dr Sebastian Bass-Stringer are both actively contributing advocates within their local stem cell communities and beyond. Their work is poised to make a lasting impact, and they both exemplify the values we all hope to inspire in our next generation of scientific leaders. The future of stem cell medicine is bright thanks to the groundbreaking contributions of our Rising Stars!

We would also like to extend our sincere gratitude to the National Stem Cell Foundation of Australia (NSCFA) for their generous support and funding, which enable us to continue fostering the development of our early-career scientists.

Please join us in congratulating Dr Chiara Pavan and Dr Sebastian Bass-Stringer on this well-deserved accolade. We look forward to their continued success.

Announcement of awards

The Rising Star Award recipients will be announced at the annual ASSCR meeting and the ASSCR AGM.

Dr Chiari Pavan

Dr Chiara  Pavan is a second-year postdoctoral researcher at The Florey Institute of Neuroscience in Melbourne, Australia. Her background stems from a Bachelor of Biotechnology (Milan University) and a Master’s in Immunology (Copenhagen University), that culminated in a PhD in Neuroimmunology (The Florey and Melbourne University) in the laboratory of Prof. Clare Parish. Her doctoral research focused on the use of human stem cells to enhance our understanding of Parkinson’s disease and for the advancement of a cell-based therapy to treat neurological conditions. With her research, she hopes to advance stem cell therapy in the clinical setting.

Dr Pavan has built a multidisciplinary and international profile, working with academia and industry to generate new Parkinson’s disease iPSC lines for disease modelling. Her expertise in neuroimmunology positioned her to tackle a major challenge in iPSC-derived grafts: that of graft rejection. Her recent Cell Stem Cell publication demonstrated effective ‘cloaking’ of iPSC from humanised immune cells in rodent models of neural engraftment. This has led to a new phase-1 trial for Parkinson’s disease.

Dr Pavan’s research has been recognised by other prizes and awards, including from the NovoNordisk Foundation, Boehringer Ingelheim Fonds Foundation, the John Milne Neuroscience Prize, the John Collier postdoctoral scholarship and the Mendelsohn Neuroscience award. In 2025, Dr Pavan was awarded the inaugural Florey-EMCR collaboration research grant, and she has completed MedTech commercialisation courses with the Association of Australian Medical Research Institutes. She was the STEM catalyst ambassador for the Australian Academy of Technological Sciences and Engineering in 2026, and has participated in outreach programs through local schools, and The Dax Centre.

Dr Sebastian Bass-Stringer

Dr Sebastian Bass-Stringer is a Senior Research Officer at St Vincent’s Institute of Medical Research (SVI), where he develops human stem cell-derived models of cardiovascular disease to advance therapeutic discovery. His research focuses on developing cardiac microtissues to model biological ageing and patient-specific diseases, including Friedreich’s ataxia-associated cardiomyopathy. By recreating key features of human cardiac disease, he aims to improve preclinical drug testing and identify promising therapies, with a particular interest in developing treatments targeting cellular senescence.

Sebastian completed his PhD at the Baker Heart and Diabetes Institute, where he developed novel gene therapies for heart failure and evaluated their safety and efficacy in preclinical models, including large animals. He subsequently joined the Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW) at the Murdoch Children’s Research Institute, where he developed CRISPR-based genetic tools to support the preclinical development and translation of an iPSC-derived cardiac cell therapy. Across his research career, he has authored 13 scientific publications, including eight as first or co-first author, spanning cardiac disease, gene therapy, stem cell biology and regenerative medicine.

Sebastian has received several competitive research awards, including a 2025 SVI Rising Star Award and a 2026 Victorian Cardiovascular Research Network Career Development Grant. He was also runner-up for the Victorian Cardiovascular Research Network’s inaugural Best Published Paper Award in 2025. His research reflects a commitment to advancing human stem cell-based disease modelling and translating fundamental scientific discoveries into more effective therapies for cardiovascular disease.

Download guidelines

Transparency matters to us, so here’s a snapshot of this year’s Rising Star applications. We received a strong submission pool representing several leading research institutes, with the majority of applicants based in Victoria and others joining from interstate. Applications were assessed by an independent panel drawn from across Australia and New Zealand, with conflicts of interest carefully managed. To everyone who applied: thank you. We encourage all applicants to apply again next year, and we’d love to see an even broader range of emerging researchers put their hands up. Please sign up here to know when awards and opportunities open again!

About ASSCR

Become a member of the ASSCR

Join NowSee all the benefits